APEN News and Press, Apollo Endosurgery Inc. From 02/22/22

Apollo Endosurgery, Inc. (APEN) Q4 2021 Earnings Conference Call February 22, 2022, 4:30 PM ET Company Participants Charles McKhann – Chief Executive Officer Jeff Black – Chief Financial Officer Matt Kreps – Investor Relations Conference Call Participants Eric Assaraf &#x...

Apollo Endosurgery press release (NASDAQ:APEN): Q4 GAAP EPS of -$0.27 misses by $0.09. Revenue of $16.2M (+26.0% Y/Y) in-line. For further details see: Apollo Endosurgery GAAP EPS of -$0.27 misses by $0.09, revenue of $16.2M in-line

Increased adoption across all product lines in both U.S. and international Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal a...

A, ACC, ADC, AGR, APEN, API, APLE, AROC, AWR, AXGN, BCC, BLKB, BNL, BRFS, BRY, BTG, BWXT, BXC, CDNS, CERS, CGBD, CSGP, CUTR, CWH, CZR, EPR, EXAS, FANG, FPI, GKOS, GMBL, GTE, HALO, HCC, HIMS, HTGC, INDI, KTOS, LAND, LILA, LPI, MAXR, MELI, MOS, MTDR, NDSN, NHI, NU, O, OMAB, PANW, PEB, PEN, OTCP...

AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financia...

Fourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced preliminary u...

$35 million funded at close to refinance existing debt, extend maturity and lower interest expense Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility AUSTIN, TX / ACCESSWIRE / December 21, 2021 / Apollo Endosurgery, Inc. ("Apollo"...

The following slide deck was published by Apollo Endosurgery, Inc. in conjunction with this event. For further details see: Apollo Endosurgery (APEN) Presents At 2021 Virtual Healthcare Conference - Slideshow

Apollo Endosurgery Inc. (NASDAQ:APEN) traded at a new 52-week high today of $10.35. This new high was reached on below average trading volume as 106,000 shares traded hands, while the average 30-day volume is approximately 277,000 shares. In the past 52 weeks, Apollo Endosurgery Inc. sha...

AUSTIN, TX / ACCESSWIRE / November 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that management will participate in four upcoming investor conference events. ...